0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aim:

          Little is known about whether pain can be effectively managed in pregnant women with opioid use disorder (OUD) during delivery hospitalization, particularly those undergoing surgery and taking buprenorphine as medication for OUD (MOUD). To address this question, we compared pain scores and opioid analgesic utilization during delivery hospitalization in women taking their pre-hospital dose of buprenorphine who delivered by cesarean section to matched controls. To inform future research efforts, we also began to explore opioid analgesic utilization and pain scores by type of anesthesia as this variable is often not included in related literature.

          Methods:

          Retrospective matched cohort study of 46 women prescribed buprenorphine during pregnancy who delivered by cesarean section during a 7-year period.

          Results:

          When compared to matched controls, women taking their pre-hospital dose of buprenorphine undergoing cesarean section utilized more opioid analgesics as measured by morphine milligram equivalents (MME) (mean MME first 48 hours 153.0 mg vs 175.1 mg, respectively, P < .01) but had similar pain scores during delivery hospitalization. There was no difference in MME utilization by maternal dose of buprenorphine though sample sizes were small. Women on buprenorphine who received spinal anesthesia with morphine had mean pain scores that were 1.4 points lower ( P = .01) during the first 48 hours than women on buprenorphine receiving other methods of anesthesia.

          Discussion And Conclusions:

          Pregnant women taking their pre-hospital dose of buprenorphine throughout their surgical delivery hospitalization were able to achieve pain relief similar to women not on MOUD but had higher MME requirements. Our results add to the emerging body of evidence suggesting that individuals on MOUD can achieve adequate post-surgical pain management without adjusting their pre-hospital dose of buprenorphine. Further research is required to fully understand the optimal buprenorphine dosing regimen during surgical hospitalizations. Our results also provide important preliminary evidence that spinal anesthesia containing opioids can be used effectively in individuals with OUD requiring surgical intervention.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder

          Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients discontinue treatment within a few weeks or months. Adverse health outcomes following buprenorphine discontinuation were compared among patients who were successfully retained beyond 6 months of continuous treatment, a minimum treatment duration recently endorsed by the National Quality Forum.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tobacco smoking in relation to pain in a national general population survey.

            We examined whether smoking status including heavy smoking (20 or more cigarettes per day) is related to the number of pain locations and intensity of pain. A probability sample of the German national population aged 18 to 79 including 7124 participants (response proportion: 61.4%) was used. All individuals underwent a health examination between 1997 and 1999. Ordinal logistic regression analyses were performed with number of pain locations and pain intensity as dependent variables which had been assessed by questionnaire. Former and current heavy smokers had higher odds for greater numbers of pain locations and for moderate and intense pain than never smokers after adjustment for analgesic medicament use and behavior-related risk factors. Female former heavy smokers had an adjusted odds ratio (OR) of 1.6 (95% confidence interval, CI, 1.2-2.2) and male former heavy smokers had an adjusted OR of 1.4 (CI 1.1-1.8) for higher numbers of pain locations compared to never smoking women and men respectively (female current smokers: OR 1.4, CI 1.0-1.9; male current smokers: OR 1.3, CI 1.1-1.7). The findings suggest that former and current heavy smokers are more likely to report more pain locations and more intense pain than never smokers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder

              To evaluate temporal trends in medication-assisted treatment utilization among pregnant women with opioid use disorder. We conducted a retrospective cohort study using Pennsylvania Medicaid administrative data. Trends in medication-assisted treatment utilization, opioid pharmacotherapy (methadone and buprenorphine) and behavioral health counselling, were calculated using pharmacy records and procedure codes. Cochrane-Armitage tests evaluated linear trends in characteristics of pregnant women using methadone versus buprenorphine. In total, we evaluated 12,587 pregnancies among 10,741 women with opioid use disorder who had a live birth between 2009 and 2015. Across all years, 44.1% of pregnant women received no opioid pharmacotherapy, 27.1% used buprenorphine, and 28.8% methadone. Fewer than half of women had any behavioral health counseling during pregnancy. The adjusted prevalence of methadone use declined from 31.6% (95% CI: 29.3%–33.9%) in 2009 to 25.2% (95% CI: 23.3%–27.1%) in 2015, while the adjusted prevalence of buprenorphine use increased from 15.8% (95% CI: 13.9%–17.8%) to 30.9% (95% CI: 28.8%–33.0%). Greater increases in buprenorphine use were found in geographic regions with large metropolitan centers, such as the Southwest (+24.9%) and the Southeast (+12.0%), compared to largely rural regions, such as the New West (+5.2%). In 2015, the adjusted number of behavioral health counseling visits during pregnancy was 3.4 (95% CI: 2.6–4.1) among women using buprenorphine, 4.0 (95% CI: 3.3–4.7) among women who did not use pharmacotherapy, and 6.4 (95% CI: 4.9–7.9) among women using methadone. Buprenorphine use among Medicaid-enrolled pregnant women with opioid use disorder increased significantly over time, with a small concurrent decline in methadone use. Behavioral health counseling utilization was low, but highest among women using methadone. Although medication-assisted treatment use during pregnancy increased over the past decade, gaps between treatment need and receipt remain.
                Bookmark

                Author and article information

                Journal
                Subst Abuse
                Subst Abuse
                SAT
                spsat
                Substance Abuse: Research and Treatment
                SAGE Publications (Sage UK: London, England )
                1178-2218
                21 June 2022
                2022
                : 16
                : 11782218221107936
                Affiliations
                [1 ]Maine Dartmouth Family Medicine Residency/MaineGeneral Medical Center, Augusta, ME, USA
                [2 ]Maine Medical Center, Portland, ME, USA
                [3 ]Department of Mathematics and Statistics, Colby College, College of Graduate and Professional Studies, University of New England, Waterville, ME, USA
                [4 ]Department of Pharmacy Practice, Westbrook College of Health Professions, University of New England, Portland, ME, USA
                Author notes
                [*]Alane B O’Connor, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102, USA. Email: aoconnor@ 123456mainehealth.org
                Author information
                https://orcid.org/0000-0002-6566-4946
                Article
                10.1177_11782218221107936
                10.1177/11782218221107936
                9218889
                bec22471-cd01-4dc2-8bb3-8c8a538a165a
                © The Author(s) 2022

                This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage).

                History
                : 17 February 2022
                : 24 May 2022
                Categories
                Original Research
                Custom metadata
                January-December 2022
                ts1

                Health & Social care
                analgesia,buprenorphine,opioid use disorder,postpartum,pregnancy,cesarean
                Health & Social care
                analgesia, buprenorphine, opioid use disorder, postpartum, pregnancy, cesarean

                Comments

                Comment on this article